Literature DB >> 19822186

Identification and characterization of estrogen receptor-related receptor alpha and gamma in human glioma and astrocytoma cells.

Mukesh K Gandhari1, Chester R Frazier, Julia S Hartenstein, Jean-Francois Cloix, Michel Bernier, Irving W Wainer.   

Abstract

The purpose of this study was to examine expression and function of estrogen receptor-related receptors (ERRs) in human glioma and astrocytoma cell lines. These estrogen receptor-negative cell lines expressed ERRalpha and ERRgamma proteins to varying degree in a cell context dependent manner, with U87MG glioma cells expressing both orphan nuclear receptors. Cell proliferation assays were performed in the presence of ERR isoform-specific agonists and antagonists, and the calculated EC(50) and IC(50) values were consistent with previous reported values determined in other types of cancer cell lines. Induction of luciferase expression under the control of ERR isoform-specific promoters was also observed in these cells. These results indicate that ERRalpha and ERRgamma are differentially expressed in these tumor cell lines and likely contribute to agonist-dependent ERR transcriptional activity. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822186      PMCID: PMC2815036          DOI: 10.1016/j.mce.2009.10.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  37 in total

Review 1.  Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand.

Authors:  B Horard; J-M Vanacker
Journal:  J Mol Endocrinol       Date:  2003-12       Impact factor: 5.098

2.  4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma.

Authors:  P Coward; D Lee; M V Hull; J M Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult.

Authors:  D J Heard; P L Norby; J Holloway; H Vissing
Journal:  Mol Endocrinol       Date:  2000-03

4.  PGC-1 and PERC, coactivators of the estrogen receptor-related receptor gamma.

Authors:  Moritz Hentschke; Ute Süsens; Uwe Borgmeyer
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

5.  Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3.

Authors:  Holger Greschik; Jean-Marie Wurtz; Sarah Sanglier; William Bourguet; Alain van Dorsselaer; Dino Moras; Jean-Paul Renaud
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

6.  Assessment of the estrogenicity of isoflavonoids, using MCF-7-ERE-Luc cells.

Authors:  Ki Eun Joung; Yeo Woon Kim; Yhun Yhong Sheen
Journal:  Arch Pharm Res       Date:  2003-09       Impact factor: 4.946

7.  Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.

Authors:  Masatomo Suetsugi; Leila Su; Kimberly Karlsberg; Yate-Ching Yuan; Shiuan Chen
Journal:  Mol Cancer Res       Date:  2003-11       Impact factor: 5.852

Review 8.  To ERR in the estrogen pathway.

Authors:  Vincent Giguère
Journal:  Trends Endocrinol Metab       Date:  2002-07       Impact factor: 12.015

Review 9.  Current chemotherapy for glioblastoma.

Authors:  Ian F Parney; Susan M Chang
Journal:  Cancer J       Date:  2003 May-Jun       Impact factor: 3.360

10.  Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.

Authors:  J N Ingle; D I Twito; D J Schaid; S A Cullinan; J E Krook; J A Mailliard; L K Tschetter; H J Long; J G Gerstner; H E Windschitl
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

View more
  7 in total

1.  Estrogen-related receptor ERRα-mediated downregulation of human hydroxysteroid sulfotransferase (SULT2A1) in Hep G2 cells.

Authors:  Chaoqun Huang; Tianyan Zhou; Yue Chen; Teng Sun; Shufen Zhang; Guangping Chen
Journal:  Chem Biol Interact       Date:  2011-04-13       Impact factor: 5.192

2.  MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor α: implications for cancer therapeutics.

Authors:  Ankana Tiwari; Swamy Shivananda; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

3.  The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein.

Authors:  J L Fiori; M Sanghvi; M P O'Connell; S M Krzysik-Walker; R Moaddel; M Bernier
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Synthesis and characterization of liquid chromatographic columns containing the immobilized ligand binding domain of the estrogen related receptor alpha and estrogen related receptor gamma.

Authors:  M Sanghvi; R Moaddel; C Frazier; I W Wainer
Journal:  J Pharm Biomed Anal       Date:  2010-06-09       Impact factor: 3.935

5.  Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.

Authors:  Nimita Dave; Lionel M L Chow; Gary A Gudelsky; Kathleen LaSance; Xiaoyang Qi; Pankaj B Desai
Journal:  Mol Cancer Ther       Date:  2015-02-18       Impact factor: 6.261

6.  Cell Models for the Study of Sex Steroid Hormone Neurobiology.

Authors:  Chang Su; Nataliya Rybalchenko; Derek A Schreihofer; Meharvan Singh; Babak Abbassi; Rebecca L Cunningham
Journal:  J Steroids Horm Sci       Date:  2012

7.  Glioblastoma cells express crucial enzymes involved in androgen synthesis: 3β-hydroxysteroid dehydrogenase, 17-20α-hydroxylase, 17β-hydroxysteroid dehydrogenase and 5α-reductase.

Authors:  Jose Antonio Mondragón; Yesenia Serrano; Andrea Torres; Martin Orozco; Jose Segovia; Gabriel Manjarrez; Marta Catalina Romano
Journal:  Endocrinol Diabetes Metab       Date:  2021-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.